Evidence map›Paper›PMID 40099975›Full record

ArticleJournal of clinical research in pediatric endocrinology2026

Thauvin-Robinet-Faivre Syndrome: A

Ülkü Gül Şiraz, Deniz Koçak Göl, Meino Rohlfs, Christoph Klein, Ekrem Ünal, Nihal Hatipoğlu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ülkü Gül ŞirazErciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri, TürkiyeORCID 0000-0001-7708-3498
Deniz Koçak GölErciyes University Faculty of Medicine, Department of Pediatric Hematology-Oncology, Kayseri, TürkiyeORCID 0000-0003-1853-3780
Meino RohlfsLudwig-Maximilians-University, Genetic Dr. Von Hauner Children’s Hospital, Department of Pediatrics, Lindwurmstr, Munich, GermanyORCID 0000-0002-2251-2387
Christoph KleinLudwig-Maximilians-University, Genetic Dr. Von Hauner Children’s Hospital, Department of Pediatrics, Lindwurmstr, Munich, GermanyORCID 0000-0003-0956-0445
Ekrem ÜnalHasan Kalyoncu University Faculty of Health Sciences; Medical Point Hospital, Department of Pediatric Hematology Oncology and Bone Marrow Transplantation Unit, Gaziantep, TürkiyeORCID 0000-0002-2691-4826
Nihal HatipoğluErciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri, TürkiyeORCID 0000-0002-0991-6539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overgrowth syndromes are rare genetic disorders arising from alterations in the growth factors pathway. These syndromes can present as generalized overgrowth, characterized by macrosomia and excessive height compared to peers, or partial overgrowth syndromes, where specific body regions exhibit disproportionate growth often accompanied by vascular anomalies. Both forms are associated with an increased risk of tumor development. The

Indexed as

Growth DisordersThyroid NeoplasmsAdolescentFemaleHumanscancerFGF-1 intracellular binding protein (FIBP) geneOvergrowth syndromes

Identifiers

PMID40099975
PMCPMC13197092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.